Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Publicis Groupe’s Saatchi & Saatchi has landed Novartis’ Excedrin account without a review, sources said.
The client spent $25 million in measured media on the brand from January through May 2005, per Nielsen Monitor-Plus.
A representative for the New York agency referred calls to client officials, who did immediately respond.
Independent agency Under the Radar in Dobbs Ferry, N.Y., had handled Excedrin since 2003.
The win is a boost for Saatchi in the pain reliever category since it lost the Tylenol account to Interpublic Group’s Deutsch in late 2003.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in